Dr Melvin Chua is the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology, and Director of the Data and Computational Science Core at the National Cancer Centre Singapore. He is also a Clinician-Scientist and Principal Investigator of the Tan Chin Tuan Laboratory of Optical Imaging, Photodynamic and Proton Beam Therapy – Precision Radiation Oncology Programme. His research is supported by the NMRC Clinician-Scientist award, and is focused on discovery and translational cancer genomics, and the development of biomarker-directed clinical trials in nasopharyngeal (NPC) and prostate cancers.

Dr Chua is a KOL on NPC and prostate cancer, and he has been invited to speak at more than 100 international meetings. He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network, a board member on the Head Neck Cancer International Group (HNCIG) and the Scientific Committee Chair of HNCIG Artificial Intelligence working group.

His other academic activities include his roles as the Associate Senior Editor of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology, and Editor-in-Chief, Annals of Nasopharynx Cancer. He also serves on the Asia-Pacific Regional Council of the American Society of Clinical Oncology (ASCO) and he is also the mentor for the ASCO Leadership Development Program. He has published over 120 peer-reviewed papers, with a H-index of 30, including highly cited articles in the New England Journal of Medicine, Lancet, Nature, Cell, Journal of Clinical Oncology and JAMA Oncology.